My Profile

Please edit your information in any of the fields below

* *Which of the following describes you best?

*When were you diagnosed with relapsing forms of MS?

* *Are you currently treating your relapsing forms of MS?
*What have you previously taken to treat your relapsing MS? Check all that apply:
* *Have you ever treated your relapsing forms of MS?

*When did you stop treating your relapsing forms of MS?

*When was the person you know diagnosed with relapsing forms of MS?

* *Is the person you know currently treating his/her relapsing forms of MS?
*What has the person you know previously taken to treat his/her relapsing forms of MS? Check all that apply:
--Please see below for Important Safety Information (ISI) and full Prescribing Information (PI) for Biogen products, including Boxed Warning and Medication Guide for TYSBRI® (natalizumab), Medication Guides for AVONEX® (interferon beta-1a) and PLEGRIDY® (peginterferon beta-1a), and Patient Information fot TECFIDERA® (dimethyl fumarate) and VUMERITY™ (diroximel fumarate). The following are trademarks of the respectives companies listed: Aubagio®-Genzyme Corporation; Betaseron®-Bayer; Copaxone®-Teva Pharmaceutical Industries Ltd.; Extavia®-Novartis AG; Gilenya®-Novartis AG; Glatopa®-Novartis AG; Lemtrada®-Genzyme Corporation; Mavenclad®-EMD Serono Inc; Mayzent®-Novartis AG; Novantrone®-EMD Serono Inc; Ocrevus™-Genentech USA, Inc.; Rebif®-EMD Serono, Inc.
* *Has the person you know ever treated his/her relapsing forms of MS?

*When did the person you know with relapsing MS stop treating his/her relapsing MS?

Please sign-in or register to view your profile.

I understand that I can choose to opt out of any future contacts at any time by clicking the "unsubscribe" link at the bottom section of TYSABRI.com or through a link provided in the emails I receive from Biogen.